Aug 22, 2024 / 11:30PM GMT
Shawn O'Brien - Mayne Pharma Group Ltd - Chief Executive Officer, Managing Director, Executive Director
Thank you, operator, and thank you all for joining. My name is Shawn Patrick O'Brien and I am the CEO and Managing Director of Mayne Pharma. We are here to present our financial results for the 12 months ended June 30, 2024, namely FY24. Joining me on this call this morning is Mayne Pharma's CFO, Aaron Grey.
On slide 2 is an important disclaimer. Today's presentation contains forward looking statements and non-IFRS financial measures, which I draw your attention to. All dollar amounts presented today are in AUD unless otherwise noted.
Now turning to our operating metrics on slide 3. I'm delighted to announce today that in FY24, Mayne Pharma has achieved 100% of our key operating metrics or goals we set for ourselves during the financial year and we're previously communicated to the market at the start of FY24.
There were five key pillars underpinning this performance, namely deliver positive direct contribution in all three segments, return the company to
Full Year 2024 Mayne Pharma Group Ltd Earnings Call Transcript
Aug 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers